» Articles » PMID: 27113728

Literature-based Discovery of New Candidates for Drug Repurposing

Overview
Journal Brief Bioinform
Specialty Biology
Date 2016 Apr 27
PMID 27113728
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Drug development is an expensive and time-consuming process; these could be reduced if the existing resources could be used to identify candidates for drug repurposing. This study sought to do this by text mining a large-scale literature repository to curate repurposed drug lists for different cancers. We devised a pattern-based relationship extraction method to extract disease-gene and gene-drug direct relationships from the literature. These direct relationships are used to infer indirect relationships using the ABC model. A gene-shared ranking method based on drug target similarity was then proposed to prioritize the indirect relationships. Our method of assessing drug target similarity correlated to existing anatomical therapeutic chemical code-based methods with a Pearson correlation coefficient of 0.9311. The indirect relationships ranking method achieved a significant mean average precision score of top 100 most common diseases. We also confirmed the suitability of candidates identified for repurposing as anticancer drugs by conducting a manual review of the literature and the clinical trials. Eventually, for visualization and enrichment of huge amount of repurposed drug information, a chord diagram was demonstrated to rapidly identify two novel indications for further biological evaluations.

Citing Articles

Genomic strategies for drug repurposing.

Dave K, Patel D, Dave N, Jain M J Egypt Natl Canc Inst. 2024; 36(1):35.

PMID: 39523244 DOI: 10.1186/s43046-024-00245-z.


DDCM: A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm.

Xu M, Li W, He J, Wang Y, Lv J, He W Int J Mol Sci. 2024; 25(10).

PMID: 38791306 PMC: 11121335. DOI: 10.3390/ijms25105267.


Enhancing the coverage of SemRep using a relation classification approach.

Ming S, Zhang R, Kilicoglu H J Biomed Inform. 2024; 155:104658.

PMID: 38782169 PMC: 11770837. DOI: 10.1016/j.jbi.2024.104658.


Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing.

Makeeva V, Dyrkheeva N, Lavrik O, Zakian S, Malakhova A Int J Mol Sci. 2023; 24(23).

PMID: 38069121 PMC: 10706709. DOI: 10.3390/ijms242316798.


Literature-based translation from synthetic lethality screening into therapeutics targets: CD82 is a novel target for mutation in colon cancer.

Yang H, Chien M, Chiang J, Lin P Comput Struct Biotechnol J. 2022; 20:5287-5295.

PMID: 36212540 PMC: 9519430. DOI: 10.1016/j.csbj.2022.09.025.